6.93

3.88% -0.28

After Hours: 6.90 -0.03 -0.43%

Candel Therapeutics Inc (CADL)

Overview News Price History Financials Discussions Forecast

Candel Therapeutics Inc stock is traded at $6.93, with a volume of 259.99K. It is down -3.88% in the last 24 hours and up +2.67% over the past month. Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Previous Close:

$7.21

Open:

$7.17

24h Volume:

259.99K

Relative Volume:

0.74

Market Cap:

$225.88M

Revenue:

$124.00K

Net Income/Loss:

$-37.94M

P/E Ratio:

-6.2432

EPS:

-1.11

Net Cash Flow:

$-34.70M

1W Performance:

-0.14%

1M Performance:

+2.67%

6M Performance:

+338.61%

1Y Performance:

+653.26%

1-Day Range:

$6.76

$7.41

1-Week Range:

$6.76

$7.41

52-Week Range:

$0.66

$14.30

Candel Therapeutics Inc Stock (CADL) Company Profile

Name

Candel Therapeutics Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

617-916-5445

Address

117 KENDRICK STREET, NEEDHAM

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CADL's Discussions on Twitter

Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-22	Initiated	H.C. Wainwright	Buy
Nov-19-21	Initiated	BMO Capital Markets	Outperform
Aug-23-21	Initiated	Credit Suisse	Outperform
Aug-23-21	Initiated	Jefferies	Buy
Aug-23-21	Initiated	UBS	Buy

Candel Therapeutics Inc Stock (CADL) Latest News

Sep 24, 2024

Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World

Sep 24, 2024

Citi raises Cogent price target on bezuclastinib potential - Investing.com India

Sep 24, 2024

Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex

Sep 24, 2024

(CADL) Proactive Strategies - Stock Traders Daily

Sep 24, 2024

Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex

Sep 24, 2024

Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily

Sep 24, 2024

Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch

Sep 24, 2024

Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga

Sep 24, 2024

Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 24, 2024

Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 24, 2024

Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks

Sep 24, 2024

Sep 23, 2024

Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch

Sep 23, 2024

Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024

Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024

Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha

Sep 23, 2024

Is it possible to buy Candel Therapeutics Inc(CADL) shares at a good price now? - US Post News

Sep 23, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World

Sep 23, 2024

Sep 22, 2024

Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 22, 2024

Kayne Anderson Rudnick Investment Management LLC Trims Stake in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 22, 2024

Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St

Sep 22, 2024

Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat

Sep 22, 2024

Sep 21, 2024

Sands Capital Ventures LLC Cuts Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

Sep 21, 2024

Sands Capital Ventures LLC Trims Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - MarketBeat

Sep 21, 2024

Sep 20, 2024

Davidson Capital Management Inc. Buys 11,978 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 20, 2024

Did Candel Therapeutics Inc (CADL) perform well in the last session? - US Post News

Sep 20, 2024

Retail investors who hold 48% of Candel Therapeutics, Inc. (NASDAQ:CADL) gained 14%, insiders profited as well - Simply Wall St

Sep 14, 2024

Sep 13, 2024

Learn to Evaluate (CADL) using the Charts - Stock Traders Daily

Sep 13, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30% - Yahoo Finance

Sep 13, 2024

Sep 04, 2024

Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewswire Inc.

Sep 04, 2024

Sep 03, 2024

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 03, 2024

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Sep 03, 2024

Sep 02, 2024